| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VIRCO MFG CORPORATION | Director | Common Stock $.01 par value | 86,278 | $702,302 | $8.14 | 17 Jun 2025 | Direct |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Director | Common Stock | 33,600 | $2,957 | $0.0880 | 30 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VIRC | VIRCO MFG CORPORATION | 17 Jun 2025 | 1 | +$49,931 | 4 | Director | 20 Jun 2025, 13:19 |
| VIRC | VIRCO MFG CORPORATION | 18 Jun 2024 | 1 | +$49,962 | 4 | Director | 21 Jun 2024, 13:15 |
| VIRC | VIRCO MFG CORPORATION | 20 Jun 2023 | 1 | +$74,805 | 4 | Director | 21 Jun 2023, 17:43 |
| VIRC | VIRCO MFG CORPORATION | 19 Sep 2022 | 1 | +$9,520 | 4 | Director | 20 Sep 2022, 16:49 |
| /report/000143774921027699-winkler-agnieszka-2021-11-15 | NAVIDEA BIOPHARMACEUTICALS, INC. | 15 Nov 2021 | 3 | +$30 | 4 | Director | 02 Dec 2021, 15:14 |
| /report/000143774921023906-winkler-agnieszka-2021-10-07 | NAVIDEA BIOPHARMACEUTICALS, INC. | 07 Oct 2021 | 0 | $0 | 3 | Director | 19 Oct 2021, 16:43 |
| VIRC | VIRCO MFG CORPORATION | 28 Jun 2021 | 1 | +$49,862 | 4 | Director | 29 Jun 2021, 17:46 |